Beijing GD Initiative Cell Therapy Technology Co., Ltd.が後援する臨床試験
合計6件
-
Xijing HospitalBeijing GD Initiative Cell Therapy Technology Co., Ltd.まだ募集していません
-
Beijing 302 HospitalBeijing GD Initiative Cell Therapy Technology Co., Ltd.; Chinese Academy of Medical Sciencesまだ募集していません
-
Beijing 302 HospitalBeijing GD Initiative Cell Therapy Technology Co., Ltd.; Chinese Academy of Medical Sciencesまだ募集していません
-
Beijing 302 HospitalCancer Institute and Hospital, Chinese Academy of Medical Sciences; Beijing GD Initiative Cell...わからない
-
Institute of Hematology & Blood Diseases HospitalCancer Institute and Hospital, Chinese Academy of Medical Sciences; Beijing GD Initiative Cell...募集
-
Institute of Hematology & Blood Diseases HospitalCancer Institute and Hospital, Chinese Academy of Medical Sciences; Beijing GD Initiative Cell...わからない非ホジキンリンパ腫 | 末梢性T細胞リンパ腫 | 再発または難治性のB細胞非ホジキンリンパ腫 | 慢性リンパ芽球性白血病中国